CTCX

0.53 -0.04 (-7.83%)

Carmell Corporation Class A · NASDAQ

Performance

+25.02%

1W

+142.25%

1M

-16.54%

3M

-65.45%

6M

+88.18%

YTD

-84.13%

1Y

Profile

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.

Technical Analysis of CTCX 2025-01-17

The Moving Average Score of 66 indicates a bullish sentiment, while the Oscillators Score of 46 and Technical Score of 56 suggest a more neutral outlook. Overall, the combined scores reflect a cautiously optimistic sentiment in the stock, driven primarily by the strong moving average performance.
Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

See more ...

Stock Analysis of CTCX

Created with Highcharts 11.1.01717009191990100
QualityGrowthMomentumValue4

Stock Rank

See more ...

Recent News & Updates

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.